Valspodar
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-1,4,7,10,12,15,19,25,28-nonamethyl-33-[(E,2R)-2-methylhex-4-enoyl]-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
Molecular Identity
Valspodar
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-1,4,7,10,12,15,19,25,28-nonamethyl-33-[(E,2R)-2-methylhex-4-enoyl]-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
PubChem CID: 5281884
SDZ PSC 833 is a homodetic cyclic peptide.
2D Structure
Properties
C63H111N11O12
Molecular Formula
1214.60
Molecular Weight
g/mol
1213.8414
Exact Mass
Da
7.7
XLogP
Above Lipinski threshold
276
TPSA
May have limited oral absorption
4
H-Bond Donors
12
H-Bond Acceptors
2410
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Valspodar121584-18-7AmdraySdz psc 833PSC-833Psc 833Sdz-psc-833PSC8333'-Keto-bmt(1)-val(2)-cyclosporin ASDZ-PSC 833Q7ZP55KF3XDTXSID90873386(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-6,9,18,24-tetraisobutyl-3,21,30-triisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-33-[(E,2R)-2-methylhex-4-enoyl]-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undeconevalspodarum(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-6,9,18,24-tetraisobutyl-3,21,30-triisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-33-((E,2R)-2-methylhex-4-enoyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Valspodar
Loading drug network...